SEC 13F Intelligence

Checkpoint Capital L.P. / TCRX

Checkpoint Capital L.P.’s Tscan Therapeutics Inc Position

Does Checkpoint Capital L.P. own Tscan Therapeutics Inc (TCRX)? Not currently — the last reported position was 2.02M shares worth $3M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q1 2025
Shares
2.02M
% of Portfolio
+1.53%
Quarters Held
3
position exited

Position History TCRX

Reported value by quarter
Q3 ’24: $4MQ3 ’24Q4 ’24: $5MQ4 ’24Q1 ’25: $3MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20252.02M$3M+1.53%
Q4 20241.76M$5M+2.72%
Q3 2024825.3K$4M+2.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of TCRX.